Effects of phthalate esters on lipid metabolism in various tissues, cells and organelles in mammals. by Bell, F P
Environmental Health Perspectives
Vol. 45, pp. 41-50, 1982
Effects of Phthalate Esters on Lipid
Metabolism in Various Tissues, Cells and
Organelles in Mammals
by Frank P. Bell*
The effect of phthalate ester plasticizers on a variety of enzyme systems was studied in rats,
rabbits and pigs. The feedingofdi(2-ethylhexyl) phthalate (DEHP) to animals at levelsfrom 0.1%
to 1.0% inthedietresulted indiverse biochemical effects, such as inhibition ofcholesterologenesis
in liver, testes, and adrenal gland; inhibition ofcholesterologenesis in brain and liveroffetal rats
from DEHP-fed dams; decreased plasma cholesterol levels; decreased synthesis of hepatic
phospholipid and triglyceride; increased fatty acid oxidation in isolated livermitochondria; and a
transient decrease in fatty acid oxidation in isolated heart mitochondria. The addition of DEHP
to preparations ofrat liver in vitro resulted in inhibition ofcholesterologenesis, and its addition to
isolated mitochondria from rat heart produced an inhibition of adenine nucleotide translocase.
DEHP-feeding to rats and rabbits, however, did not affect platelet function as judged by
collagen- andADP-induced aggregation. The studies presented here indicate thatthe exposure of
animals tophthalate esters canresult in asignificant perturbation ofnormal metabolism in liver,
heart, testes, adrenal gland and brain and can affect blood lipid levels.
Introduction
A number of reviews (1-5) have thoroughly
outlined the synthesis, properties, and industrial
application ofthe phthalate esters in use today. The
utility of the phthalates is so diverse that annual
production in the USA alone is estimated at 1-2 x
109 lb, with worldwide production reaching about 4
x 109 lb (5). The widespread use ofphthalates and
phthalate-containing products in all segments of
society has, within the span of a few decades,
resulted in global contamination by this class of
compounds. The presence of phthalate esters in
virtually all ecosystems (5-17) and in the tissues of
man (18-22), animals (6, 7, 9, 11, 16, 23, 24), and in
the food supply of man (24-26) is a shocking
revelation.
Phthalates were evaluated in the 1940s and 1950s
by classical toxicological criteria andjudged to have
a low order of acute and chronic toxicity (27-30). It
was not until the 1960s that the safety of the
phthalates came into serious question. During the
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1960s, scattered reports appeared in medical jour-
nals citing concern over the possible toxic effects of
poly(vinyl chloride) (PVC) plastic medical devices
which contained phthalate esterplasticizers (31-36).
Concern over phthalate toxicity heightened with
reports by Marcel and Noel (37, 38) andJaeger and
Rubin (39, 40) in 1970 that stored human blood was
being contaminated with phthalate ester, namely,
di(2-ethylhexyl) phthalate (DEHP), while stored in
PVC plastic blood bags. It was subsequently shown
thattissuesfrompatientsrecentlytransfusedand/or
exposed to PVC plastic catheters accumulated
detectable levels of DEHP in their tissues (18-21).
During the same period (1970-1975), a wide variety
of biological studies appeared in the literature
whichfurtherchallenged the safetyofthephthalates
(24, 41-50); these provided evidence that the
phthalates could accumulate in mitochondria (24)
and that phthalates were teratogenic (41-43), muta-
genic (44), toxic to various types of cultured cells
(45-47), capable of placental transfer (48), capable
of altering hepatic ultrastructure (49) and capable
of promoting hepatic lipid accumulation under cer-
tain conditions (50).
What was surprising to me, however, was that as42
late as 1975, the knowledge that had accrued
concerning phthalate toxicity was devoid ofstudies
on the effects of phthalate esters on biochemical
pathways and events, which by necessity would
underlie the qualitative toxic responses being
observed. It was for this reason, in 1975, that
efforts in my laboratory were directed towards
investigatingthepossible effects ofphthalate esters
on lipid metabolism in various species. The obser-
vations presented in this paper summarize results
of studies which were initiated in 1975 and which
have continued up to the present time. The studies
were conducted in rats, rabbits and pigs. Depend-
ing upon the nature of the study, phthalate esters
were either fed as an admixture to the diets or
added, in vitro, to tissue preparations. Details of
the techniques and methods used throughout the
studies have been described elsewhere and will be
referenced in the table footnotes and figure leg-
ends. Statistical analyses were performed using
Student's independent t-test.
Results and Discussion
Effects of Phthalate Esters on Sterol
Metabolism
The reports that phthalate esters possess terato-
genic andmutagenic potential (41-44) suggested the
possibility oftheir interference with sterologenesis
which is a key process in mammalian development.
This, in fact, proved to be the case, and the evi-
dence was first published in 1976 (51, 52).
Liver (MaleRats). An inhibition ofcholesterol
synthesis from '4C-acetate is apparent within 48 hr
after feeding 0.5% DEHP to male rats (Table 1).
The inhibition is progressive and rises from 14% at
2 days.to 70% by 11 days. Inhibition of labeled
mevalonate incorporation into cholesterol by 0.5%
DEHP feeding also occurs but is slower to develop;
inhibition is not apparent until after 6 days of
DEHP exposure. By 11 days, cholesterologenesis
from'H-mevalonate is inhibited about40%. The lag
period in the development of inhibition of hepatic
cholesterologenesis from mevalonate relative to ace-
tate has been observed underotherconditions which
result in inhibition of cholesterologenesis (54). The
incorporation of mevalonate into cholesterol can
eventually be suppressed to the same extent as
acetate incorporation, as revealed by livers from
rats fed DEHP for 18 days (Table 1). The data in
Table 1 suggest that the site of action of phthalate
is at the level of HMG CoA reductase (3-hydroxy-3-
methylglutaryl CoA reductase, EC 1.1.1.34) (55),
the first rate-limiting step in hepatic sterol synthe-
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Table 1. Effect ofDEHP feeding on cholesterlogenesis from
14C-acetate and 3H-mevalonate in liver minces from male
rats.a
Incorporation into cholesterol,
Level % of control
of DEHP Duration of
in diet, % feeding, days 14C-Acetate 3H-Mevalonate
0.5 0 100 100
2 86 104
4 63 100
6 39 91
11 30 61
1.0 18 29 22
aMale Sprague-Dawley rats (300-325 g) were fed Purina Chow
(control) or Purina Chow containing di(2-ethylhexyl) phthalate
(DEHP) (52, 53),at levels of 0.5% or 1.0% (w/w). Liver minces
were prepared and incubated for 3 hr in 4.0 ml (0.5% study) or
3.7 ml (1.0% study) ofKrebs-Ringer-bicarbonate buffer, pH 7.4,
which contained 4 ,Ci sodium acetate-1-_4C (SA 58 mCi/mmole)
and2.4 uCiDL-mevalonic-5-3Hacid(DBEDsalt, SA6.7Ci/mmole)
(52). Afterincubation, the samples were hydrolyzed (saponified)
with alcoholic KOH, and then the neutral sterols were extracted
with n-hexane and subsequently fractionated by thin-layer
chromatography (52). Valuesaremeansoftwoorthree DEHP-fed
animals expressed relative to control values obtained in parallel
experiments.
sis (56) (Fig. 1). Inhibition at this site would first
affect the flow-through of acetate to cholesterol as
demonstrated in Table 1 (and diagrammed in Fig.
1) and permit the inhibition to be circumvented
initially by use of exogenous mevalonate as a sub-
strate. The inhibition ofsterologenesis fromlabeled
mevalonate which developslater(after6days, Table
1) may be explained if one or more ofthe enzymes
between mevalonate and cholesterol are substrate-
induced andtherebydeclineinactivityasmevalonate
production diminishes.
In all studies, the decreased synthesis of choles-
terol was paralleled by decreases in synthesis of
lanosterol and squalene (52), as would be antici-
pated from Figure 1. Additionally, the cholesterol
content of livers from rats fed 0.5% DEHP for 6
days was not differentfromthatofcontrolrats (52),
HMGCoA
Reductase
Acetate >- HMGCoA o Mevalonate
Cholesterol . - Lanosterol - Squalene
FIGURE 1. Cholesterol, the principal C27 sterol of liver, is
derived from units ofacetyl CoA via asequence of20 ormore
intermediates (57) which include 3-hydroxy-3-methylglutaryl
CoA (HMG CoA), mevalonic acid, squalene (a C30 hydrocar-
bon) and lanosterol (a C30 sterol). The conversion of HMG
CoA to mevalonate by HMG CoA reductase (EC 1.1.1.34) is
the primary rate-limiting step in the formation of squalene
and sterols (56). Secondary control sites beyond mevalonate
may also function (54, 56-58).EFFECTS OF PHTHALATE ESTERS ON LIPID METABOLISM
Table 2. 1'C-Acetate incorporation into sterols of normal
male rat liver minces: inhibition by exogenously added
DEHP.a
"'C-Acetate incorporation into
DEHP concn, digitonin-precipitable sterols,
mm n % of control
0.0 9 100 ± 0
0.25 6 92±15
0.50 6 75±12
1.0 4 87 ± 7
2.5 8 54 ± 6
'Livers from normnal male Sprague-Dawley rats (275-300 g,
maintained on Purina Chow) were used to prepare minces (500
mg) (59) which were incubated for 3 hr in 3.5 ml Krebs-Ringer-
bicarbonate buffer, pH 7.4. Assays were initiated by the
addition of 2 ~Ci sodium acetate-1_"4C (SA 58.3 Ci/mole) and
DEHP. DEHP was added as a Tween-20-stabilized dispersion
(60). After incubation, the samples were hydrolyzed with
alcoholic KOH (52). The nonsaponifiable lipids were recovered
byextractionwith n-hexane (52) and the313-H sterols (principally
cholesterol) were precipitated with digitonin and assayed for
radioactivity (52,59). Values are means ± SEM ofthe number of
animals designated by n.
thus indicating that DEHP-induced inhibition of
hepatic cholesterologenesis is unlikely to be attrib-
uted to end product inhibition. In fact, feeding of
phthalates for longer periods (21 days) tends to
reduce hepatic cholesterol (55). End product inhibi-
tion is also inconsistent with the observation that
DEHP inhibits 14C-acetate incorporation into ste-
rols when added directly to normal male rat liver
minces (Table 2).
Liver (Female Rats). Studies in female rats
fed 1.0% DEHP for 13 days (61) indicated that
inhibition ofhepatic sterologenesis is notsex-specific
(Table 3).
Liver (MaleRabbits). Inhibition ofsterologen-
Table 3. Effect of DEHP feeding on the incorporation of
"4C-mevalonate into sterols and squalene by liverminces from
female rats.'
Incorporation, dpm/g wet wt
C27 + C30 sterols Squalene
Control 40520 ± 2440 56870 ± 5175
1%DEHP 29635±3645 24355±2490
p<0.05 p<0.001
aFemale Sprague-Dawley rats (245-255 g) were fed either
Purina Chow or Purina Chow supplemented with 1.0% DEHP
(wlw) for 13days. Liver minces (500mg) were incubated for 3 hr
at 370C in 3.4 ml Krebs-Ringer-bicarbonate buffer, pH 7.4,
containing 1 p.Ci DL-mevalonic-2-14C acid (DBED salt, SA 40.8
Ci/mole). After incubation, the samples were hydrolyzed with
alcoholic KOH, the nonsaponifiable lipids were extracted with
n-hexane (52) and fractionated by thin-layer chromatography to
yield C27 sterols (principally cholesterol), C30 sterols (principally
lanosterol) and squalene (52). Values are means ± SEM of six
animals per group.
Table 4. Effect of DEHP feeding on the incorporation of
'H-mevalonate into sterols and squalene by rabbit liver
minces.'
Incorporation, dpm/g wet wt
C27 sterol C30 sterols Squalene
Control 28890 ± 6880 9115 ± 2610 33080 ± 11360
1% DEHP 12140 ± 2815 3945 ± 655 13675 ± 5490
p<0.05 p<O.Ol
'Male New Zealand rabbits (2.5-3 kg) were fed Purina Chow
Pellets or 1% DEHP (w/w) as an admixture in Purina Chow
Pellets for 28 days. Liver minces (500 mg) were prepared and
incubated for 3 hr at 370C in 3.5 ml Krebs-Ringer-bicarbonate
buffer, pH 7.4, which contained 0.25 p.Ci DL-mevalonic-5-3H(N)
acid (DBED salt, 5 Cilmmole). After incubation, the samples
were treated with alcoholic KOH to hydrolyze the tissue and to
saponify the lipids. The neutral sterols and squalene were
extracted with n-hexane and subsequently fractionated by
thin-layer chromatography. Values are means ± SEM of six
animnals.
esis in liver from rabbits fed DEHP (59) also dis-
missed the possibility that the effect of DEHP is
species-specific for the rat (Table 4).
AdrenalandTestes. Inhibitionofsterologenesis
in DEHP-fed animals is not restricted to the liver.
The results ofTable 5 show that adrenal glands and
testes are similarly affected (59, 61), with inhibition
reaching 20-25% of normal synthesis. Impaired
sterologenesis in adrenal and testicular tissue may,
in part, be responsible for the developmental abnor-
malities (62) reported to occur in fetuses from
phthalate-treated dams (41, 42, 46) and for testicu-
lar atrophy in young and adult animals (63-67).
Developing Fetuses and Suckling Offspring.
Placental transfer of DEHP has been reported in
rats (48). The exposure of the developing fetus to
DEHP by this route may have important implica-
tions in the development ofthe fetus. The results of
Table 6 indicate that fetuses taken by cesarean
section from pregnant rats fed DEHP beginning 5
to 10 days after conception have an impairment of
sterologenesis in brain and liver (68). Furthermore,
if dams exposed to DEHP during gestation, and
during the postnatal period as well, are permitted
to nurse their naturally born offspring, hepatic
sterologenesis in the pups is reduced below control
values (Table 7). In 8-day suckling rats, hepatic
sterologenesis was reduced 20% below control val-
ues and was accompanied by increased liver size
and decreasedbodyweight(Table7). The decreased
body weight seen in the 8-day-old pups was not
apparent in litters permitted to reach weaning age
(21 days) (Table 8). DEHP feeding to the dams
resulted in a significant lowering of plasma choles-
terol (p <0.02) but did not affectplasma cholesterol
levels in the pups (Table 8).
43Table 5. Effect ofDEHP feedingon the incorporation of14C-mevalonate into C27 + C30 sterols and squalene inrat adrenal gland
and testis.'
Duration of Incorporation, dpm/100 mg wet wt
Organ Diet study, days Sterols Squalene
Adrenal (Y) Control 13 352 ± 23 124 ± 10
p < 0.01 NS
1% DEHP 13 266 ± 8 105± 7
Adrenal (d) Control 73 322 ± 20 84 ± 4
p < 0.02 NS
1% DEHP 73 264 ± 12 66 ± 10
Testis Control 28 233 ± 15 212 ± 9
p < 0.02 p < 0.01
0.5% DEHP 28 175 ± 12 149 ± 13
'Sprague-Dawley rats ofboth sexes were fed Purina Laboratory Chow orthe chow diet supplemented with DEHP. Adrenal glands
were removed from females (body wt 251 ±3 g, n = 12) and males (body wt 320 ±20 g, n = 10), dissected free ofadhering tissue and
capsular material, and then incubated for 3 hr at 37°C in 1.52 ml of Krebs-Ringer-bicarbonate buffer, pH 7.4, containing 1.0 ,uCi
DL-mevalonic-2-14C acid (DBED salt, 40.8 Ci/mole). Testes (right side) from rats weighing225-250 gwere decapsulated and incubated
as the whole gland for 3 hr at 37°C in 5.0 ml Krebs-Ringer-bicarbonate buffer, pH 7.4, containing 2.5 RCi DL-mevalonic-2-'4C acid
(DBED salt, 40.1 Ci/mole). Afterincubation, the tissues were treated with alcoholic KOH as described in the footnote to Table 1. The
neutral sterols and squalene were extracted with n-hexane and subsequently fractionated by thin-layer chromatography. Values are
means ± SEM (male adrenals, n = 5 per group; all others, n = 6 per group).
Table 6. DEHP feeding to rats during gestation: effect on the incorporation of radiolabeled acetate and mevalonate into
cholesterol in fetal brain and liver.'
Incorporation of labeled compound into cholesterol
Expt. Labeled 14C-Acetate '4C-Mevalonate, 3H-Mevalonate, dpm/
no. Treatment compound dpm/brain dpm/brain mg dry wt of liver
1 Pregnant rats were fed 0.5% DEHP for 13 days Control 13570 ± 700 6680 ± 300
beginning on the 5th day ofgestation. Fetuses n = (7) n = (14)
were taken by cesarean section op the 18th day DEHP 11510 ± 520 5675 ± 220
ofgestation. Brains were obtained from seven n = (7) n = (13)
fetuses from seven different dams. Livers were p < 0.05 p < 0.02
obtained from fetuses from up to eight dams; not
more than two fetuses per dam were used.
2 Pregnant rats were fed 1.0% DEHP for 8 days Control 25300 ± 1795 4990 ± 490
beginning on the 10th day ofgestation. Fetuses (n = 8) (n = 9)
were taken by cesarean section on the 18th DEHP 18375 ± 2240 3010 ± 170
day ofgestation. Brains and livers were (n = 6) (n = 6)
obtained from fetuses from two to three p < 0.05 p < 0.01
different dams.
'Livers and brains were incubated as the entire tissue for 3 hr at 37°C in 3.5 ml Krebs-Ringer-bicarbonate buffer, pH 7.4.
Radioactive precursors (acetate-1-14C, sodium salt, SA 59 Ci/mole, DL-mevalonic acid-2-14C, DBED salt, SA 46 Ci/mole, and
DL-mevalonic acid-5-3H, DBED salt, SA 5 Ci/mmole) were present at a level of2,uCi.
Plasma Cholesterol. Certain phthalate esters
evoke a hypocholesterolemic response in rats of
either sex (Tables 8 and 9). At levels of 0.5% and
1.0% in the diet, DEHP reduces plasma cholesterol
about 20% in the male rat (Table 9) (55, 59, 69); this
reduction appears torepresent amaximumresponse
inasmuch as 0.5% and 1.0% DEHP appear to have
equivalent effects (55, 59, 69). The maximum chole-
sterol-lowering effect occurs within the first week
ofDEHP feeding (55). Since a hypocholesterolemic
effect ofphthalates has also been observed in mice
(70)butnotinrabbits(59, 69), thisresponse appears
to have some degree of species specificity.
Comparison ofDimethylPhthalate (DMP), Di-
n-butyl Phthalate (DBP) and Di-2-ethylhexyl
Phthalate (DEHP). In rats fed DMP, DBP or
DEHP at a level of25 mmole/kg diet (equivalent to
1.0% DEHP) for 21 days, DEHP and DBP reduced
plasma cholesterol levels 16% and 2, respectively,
and inhibited hepatic cholesterologenesis fromlabeled
mevalonate by 67% and 30%, respectively (Table
9). It is possible that the hypocholesterolemic effect
of DBP and DEHP is a direct consequence of the
inhibition ofhepatic sterologenesis, although other
mechanisms could be possible. Since inhibition of
hepaticsterologenesis fromlabeledmevalonate (Table
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Table 7. Incorporation of "4C-mevalonate into sterols in livers of 8-day-old suckling rats from dams fed 0.5% DEHP during
gestation and throughout the postnatal period.'
Incorporation into C27 + C30
Pup wt, g Liver wt, % body wt sterols, dpm/g wet wt x 1072
Control 21.7 ± 0.3 2.75 ± 0.03 3906 ± 280
DEHP 18.8 ± 0.7 3.01 ± 0.06 3107 ± 208
p < 0.01 p < 0.01 p < 0.05
'Pregnant rats were fed 0.5% DEHP in the diet (w/w) beginning on the 5th day ofgestation and were permitted to deliver and to
nurse the pups for 8 days; the DEHP diet was continued throughout the entire postnatal period. Liver minces were prepared from
each pup and incubated 3 hr at 37°C in 3.5 ml of Krebs-Ringer-bicarbonate buffer, pH 7.4, which contained 2,uCi DL-mevalonic-5'H
acid, (DBED salt, SA 5 Ci/mmole). Control pups (n = 10) were from 1 dam; pups in the DEHP group (n = 12) came in equal numbers
from two dams.
Table 8. Plasma cholesterol levels in DEHP-fed nursing dam rats and their suckling pups.'
n Body wt, g Total plasma cholesterol, mg/dl
Controls
Dams 4 363 ± 6 61 ± 5b
Pups 41 46 ± 1 102 ± 2
DEHP-fed
Dams 4 353 ± 6 37 + 6b
Pups 26 48 ± 1 102 ± 4
'Female rats were fed Purina Laboratory Chow or the chow supplemented with 0.5% DEHP (w/w) from the first day ofgestation
until the pups were weaned at 21 days. Cholesterol was measured as described (59). Values are means ± SEM of the number of
animals designated by n.
bSignificant, p < 0.02.
Table 9. Effect of feeding various phthalate esters on lipid metabolism in the rat.'
Incorporation of
"4C-mevalonate into
Liver weight, Total liver Liver cholesterol, Total plasma cholesterol in liver,
% body wt lipid, mg/g wet wt mg/g wet wt cholesterol, mg/dl % of control
Control 4.0 ± 0.1 42.7 ± 1.4 4.5 ± 0.2 87 ± 5 100
DMP 4.1 ± 0.2 38.5 ± 1.2b 3.1 ± 0.2c 80 ± 3 114 ± 21
DBP 4.6 0.lc 47.3 ± 2.2 3.8 ± 0.2 69 ± 3b 70 ± 6b
DEHP 6.8 0.2' 44.2 ± 1.0 4.1 ± 0.1 73 ± 5b 33 ± 8c
'Male Sprague-Dawley rats were fed Purina Chow (control) or the chow containing dimethyl phthalate (DMP), di-n-butyl phthalate
(DBP), or di(2-ethylhexyl) phthalate (DEHP); the phthalates were present at a level of2.5 mmole/100g feed. The diets were fed for21
days. Details of the analyses have been presented (55). All values are means ± SEM of 5-10 observations.
bp < 0.05, Student's independent t-test.
Cp < 0.001, Student's independent t-test.
9) and labeled acetate (55) is greater with DEHP
than DBP and since DMP does not have this action
(Table 9) (55), the presence of a two-carbon alkyl
chain appears to be the minimum requirement for
inhibition of sterologenesis.
DMP differed from DBP and DEHP in two other
respects; it reduced liver total lipid and liver total
cholesterol (Table 9), whereas DBP and DEHP
showed no significant effect on these parameters.
Additionally, DMP did not produce hepatomegaly
as did DBP and DEHP (Table 9). The increased
liver size in the DBP- and DEHP-fed animals
appeared to represent a true increase in tissue
mass rather than an edematous change since the
ratio oflipid-free dry weight to wet weight ofliver
was similar to control values (55).
Effects of DEHP Feeding on
Biosynthesis of Fatty Acids and
Glyceryl Lipids in the Rat
Feeding DEHP to rats affects not only sterol
synthesis as mentioned previously, but synthesis of
other lipids as well. Interestingly, not all tissues
appear to be affected to the same extent or in the
same manner. The incorporation of 1-14C-acetate
into fatty acids, phospholipids and triglycerides
was not statistically significantly altered, in vitro,
in heart and aorta ofmale rats fed 0.5% DEHP for
10 days (Table 10). By contrast, 1-_4C-acetate in-
corporation into these same lipids was reduced
about 40% in liver; total 14C-labeled lipid synthesis
(includes sterols) wasalsoreducedabout48%(Table
45Table 10. Effect ofDEHP feeding (0.5%) on the incorporation of"C-acetate intofatty acids and glyceryl lipids invarioustissues
of the rat, in vitro.a
"C-Acetate incorporation, dpm/g wet weight
Tissue Group Phospholipid Triglyceride Free fatty acid Total lipid
Aorta Control 320 ± 105 295 ± 150 290 ± 120 1225 ± 440
DEHP 205 ± 75 315 ± 175 200 ± 60 965 ± 350
Heart Control 1765 ± 165 1095 ± 90 1895 ± 200 6755 ± 465
DEHP 1500 ± 145 1085 ± 135 1515 ± 80 6245 ± 470
Kidney Control 2470 ± 220 1945 ± 220b 1775 ± 145 8400 ± 435
DEHP 2060 ± 130 1315 ± lOOb 2185 ± 120 8095 ± 350
Liver Control 695 ± 80C 625 ± 105b 945 + 140c 3525 ± 455c
DEHP 425 ± 40c 370 ± 65b 500 ± 60c 1860 ± 165C
p < 0.02 p < 0.05 p < 0.02 p < 0.02
aMale Sprague-Dawley rats were fed Purina Chow (control) or the chow containing 0.5% DEHP (w/w) for 10 days. Tissue slices
were prepared from liver, heart and kidney and incubated for 3 hr at 37°C in 5.0 ml of Krebs-Ringer-bicarbonate buffer, pH 7.4,
containing 4 RCi sodium acetate-1-_4C (SA 58.6 mCi/mmole) (53). Aortas were incubated under exactly the same conditions with the
exception that the tissue was bisected longitudinally rather than sliced. All values are means ± SEM of six animals.
bSignificant, p < 0.05.
cSignificant, p < 0.02.
10). In kidney, 14C-acetate incorporation in triglyc-
erides was reduced 33%, whereas synthesis of the
fatty acids and phospholipids was not significantly
altered by DEHP feeding (Table 10). Fractionation
of the hepatic phospholipids synthesized from 14C-
acetate in rats fed 0.5% DEHP showed asignificant
reduction in the distribution of 14C-acetate into the
phosphatidylcholinefractionoftheliverphospholipids
(53). In addition, feeding 0.5% DEHP to male rats
for 9 days resulted in 37-44% reduction in the
esterification of3H-oleate into diglycerides and tri-
glycerides in liver minces (55). The above studies
suggest that DEHP can, in certain tissues, inhibit
de novo fatty acid synthesis, decrease fatty acid
esterification, andselectively affect the synthesis of
specific phospholipid species; the latter has been
confirmed chemically as well (17).
Effects of DEHP on Mitochondrial
Function
The ability of DEHP to accumulate in heart
tissue of animals (23, 24) and man (21) and, more
specifically, toaccumulate inthemitochondrial frac-
tion of heart tissue (23, 24) suggested a need to
investigate possible biochemical effects of DEHP
on mitochondrial function.
Fatty Acid Oxidation in Heart andLiverMito-
chondriafromRat,RabbitandPig. DEHPfeeding
to rats, rabbits and pigs resulted in an increased
capacityoftheirlivermitochondriatooxidizepalmitic
acid (72). In suitably prepared suspensions of iso-
lated mitochondria, the oxidation of 14C-palmitoyl
CoA was enhanced two- to threefold after several
days' exposure totheDEHP(Table 11). Theenhanced
capacity to oxidize 14C-palmitoyl CoA substrate
wasundiminished throughoutthe longest periods of
exposure studied (i.e., 12 days in rabbits and 35
days in rats). In the rat, the maximum response
appeared at alevelof0.1% DEHPinthe diet (Table
11). The response of heart mitochondria to DEHP
feeding was markedly different from that shown in
liver. Ingestion of 0.1% DEHP for 2 days resulted
in a 25% reduction in fatty acid oxidation by heart
mitochondria. Theinhibitionincreasedtoabout50%
in 3 to 4 days (Table 11). The inhibition, however,
appears to be a transient effect, since full oxidizing
capacity is restored in 8 or 9 days even though
DEHP-feeding is continued. The addition of DL-
carnitine and cofactors to heart mitochondria from
rats fed DEHP for 5 days resulted in a stimulation
of 14C-palmitoyl CoA oxidation (Table 12). This
suggests that the inhibition is not a result of func-
tional change in the fatty acid oxidation system of
the mitochondria.
MitochondrialAdenineNucleotide Translocase.
Adenine nucleotide translocase is one of the mito-
chondrial anion translocators. It is located in the
inner mitochondrial membrane and is responsible
for affecting a mole:mole exchange of extramito-
chondrial ADPforintramitochondrialATP. Itis via
this specific mechanism that ATP generated by
oxidative phosphorylation can be transported into
thecytoplasmatosupportcytosolicenergy-requiring
reactions. The addition of DEHP to suspensions of
isolated heart mitochondria results in an inhibition
of adenine nucleotide translocase. Activity of the
transporter was reduced 37% by 300 ,uM DEHP
(Fig. 2). Such an effect of DEHP may be the
mechanismunderlyingthe death ofmyocardial cells
cultured in the presence ofDEHP (45, 74) and may
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Table 11. Effect of oral ingestion of DEHP on the oxidation of "C-palmitoyl CoA in isolated heart and liver mitochondria.'
Duration, Dpm '4CO2/mg protein, No. of
Tissue Species Dose days % of control observations
Heart Rat 0.1% in diet 2 77 1
3 55 ± 25 3
4 55 2
9 110 1
Rat 0.5% in diet 4 61 2
9 103 ± 14 6
Rat 1.0% in diet 9 98 2
16 105 ± 5 5
Liver Pig 0.8 mg/kg per os, b.i.d. 2 170 2
Rabbit 1.0% in diet 12 236 ± 77 4
Rat 0.1% in diet 2 284 1
3 191 ± 1 3
4 299 1
Rat 0.5% in diet 4 548 2
8 272±16 3
10 199 ± 21 3
16 329 2
Rat 1.0% in diet 16 227 ± 15 3
35 278 2
aMitochondria were isolated as previously described (72) and incubated for 3 hr at 37°C in the presence of1-14C-palmitoyl CoA (SA
56 Ci/mole). Oxidation of 14C-palmitoyl CoA was assessed by measuring 14C02 production (72).
Table 12. Stimulation of "4C-palmitoyl CoA oxidation by
carnitineandcofactors inheartmitochondriafromDEHP-fed
rats.a
Additions to '4CO2 production, dpm/mg
incubation medium mitochondrial protein
None 2100
DL-Carnitine 2740
ATP, CoA-SH 4660
ATP, CoA-SH, DL-carnitine 5710
aMale Sprague-Dawley rats (225-250 g) were fed Purina
Laboratory Chow containing 1.0% DEHP (w/w) for 6 days.
Mitochondria were isolated from pools of two hearts, and all
assays were performed in triplicate (see footnote to Table 11) in
a total volume of 7.0 ml (72). When present, the levels of the
various cofactors in the incubation mixtures were: ATP, 15 mg;
CoA-SH, 4 mg; NaF, 0.8; MgCl6H20, 3 mg. DL-Carnitine *HCl
was added to a final concentration of2.6 mM.
also be related tothe decrease in spontaneous heart
rate that is observed in rat hearts perfused with
DEHP-containingmedium (75, 76). Despite the fact
that DEHP accumulates in the hearts ofDEHP-fed
rats (50), we did not observe a change in adenine
nucleotide translocase activity in mitochondria iso-
lated from hearts ofrats fed 0.5% DEHP for up to
10 days (73). The fact that DEHP inhibited adenine
nucleotide translocase when added directly to mito-
chondria, but notwhenfedtotherats, mayindicate
that the level of DEHP accumulating in the hearts
during the 10-day feeding trials was insufficient to
significantly affect the enzyme.
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FIGURE 2. Inhibitionofmitochondrial adeninenucleotidetrans-
locase. Mitochondria were isolated from normal male rat
heart and assayed (73) in the presence ofvarious concentra-
tions ofDEHP. Values are means of 15 animals at20, 40 and
60 M DEHP and means ofthree to four animals at all other
levels.
Effect of DEHP Feeding on Platelet
Lipid Synthesis and Function in
Rats and Rabbits
The well-known fact that blood and blood prod-
ucts become contaminated with DEHP during stor-
47Table 13. Effect of DEHP feeding on platelet function and prothrombin time.a
Platelet number Aggregation Prothrombin
Species Group x 106/mm3 Collagen-induced ADP-induced time, sec
Rat Control 1.57 ± 0.03 30.7 ± 6.1 27.8 ± 1.9 12.7 ± 0.3
DEHP-fed 1.66 ± 0.09 35.7 ± 4.9 30.2 ± 2.6 11.6 ± 0.3
Rabbit Control 0.61 ± 0.05 18.0 ± 3.6 - 5.5 ± 0.1
DEHP-fed 0.60 ± 0.04 17.9 ± 1.9 - 5.6 ± 0.1
aMale New Zealand rabbits (2.5-3 kg) and male Sprague-Dawley rats received Purina Chow orthe chow supplemented with DEHP.
Rats (150-160 g at beginning of study) received 0.5% DEHP for 32 days and rabbits received 1.0% DEHP for 28 days. All methods
used are detailed elsewhere (69). Values are means ± SEM of six animals in each control group, and seven animals in each treated
(DEHP) group.
age in PVC plastic storage bags has caused great
concern because oftheuncertainty astowhat DEHP
may do to blood cell physiology (77). For example,
it has been reported that DEHPmay cause increased
platelet aggregation in blood stored in PVC storage
bags (45), increased platelet adhesion to artificial
surfaces (78) and decreased survival of platelets
stored in the frozen state in PVC bags (79). In view
of the above, we studied the function of platelets
exposed to DEHP in vivo through a regimen of
DEHP feeding. DEHP was fed in the diets ofrats
(0.5%) and rabbits (1.0%) for32and28days, respec-
tively. At the end of the feeding period, platelet
function was studied. Synthesis of phospholipids
and sterolsbytheplatelets wasalsostudiedbecause
of the importance of these two lipid classes to
membrane structure and stability (80), particularly
sinceplatelet aggregationisamembrane-dependent
phenomenon. DEHP feeding did not affect phos-
pholipid synthesis from acetate-1-14C, or sterol syn-
thesis from mevalonic-5-3H acid, in platelets from
young (6-week-old) or old (5-month-old) rats (69).
Additionally, the feeding of DEHP did not signi-
ficantly (p > 0.05) alter platelet number, collagen-
induced platelet aggregation orADP-induced aggre-
gation in either the rabbit or rat (Table 13). Pro-
thrombintime was alsoessentiallyunchanged (Table
13). The results suggest that the increased sensitiv-
ity of platelets exposed to DEHP in vitro (45, 78,
79) does not accurately reflect their response to
DEHP exposure in vivo.
Conclusions and Suggestions
The data presented here make it abundantly
clear that the exposure of animals to phthalate
esters can result in a significant perturbation of
normal metabolic patterns in liver, heart, testes,
adrenal gland and brain and can affect blood lipids
(51-53, 55, 59-61, 68, 69, 72, 73, 77). The ability of
phthalates to alter lipid metabolism in the develop-
ing fetus and in suckling animals is also apparent
and becomes a point of particular concern. At the
time ofthis writing, no published biochemical stud-
ies similar to those reported here have been con-
ducted in tissues from subhuman primates or man;
such studies are urgently needed in order to assess
moreaccuratelythepotentialhazardofthephthalates
to human health. At the present time, the concern
of the medical profession over the exposure of
patients to phthalates while undergoing medical
treatment has attracted widespread attention in
government and industry. Hopefully, the concern
over the use ofphthalate-containing devices in the
field of medicine will attract greater attention to
the more important issue of what potential health
hazards mankind is exposed to as a result of invol-
untary chronic exposure to phthalates in the envi-
ronment. Evidence that chronic exposure ofman to
DEHP may result in neurological disorders has
been reported (81). A further point to be made is a
suggestion thatpharmacokinetic studieswithphtha-
lates should be less preoccupied with tissue distri-
bution and more concerned with subcellular distri-
bution; the reasoning follows. Much of the work
described here has been concerned with biochemi-
cal systems dependent upon the activity of mem-
brane-bound (particulate) enzymes-e.g., sterol syn-
thesis (HMG CoA reductase), adenine nucleotide
translocase, and fatty acid oxidation. Membrane-
bound enzymes, in general, are sensitive tochanges
in membrane fluidity which reflects alterations in
the physical state of the membrane-lipids (82, 83).
The possibility exists that the effects ofphthalates
(inhibitory or stimulatory) on various membrane-
bound enzymes is an indirect effect of their ability
to modify membrane fluidity. Being lipophilic, the
phthalatescanpartitionacrossorganellarmembranes
and perturb the composition and physical state of
the lipid microenvironment (domain) surrounding
certain particulate enzymes. Since the response of
specific membrane-bound enzymes to changes in
membrane fluidity cannot be determined apriori, it
is not inconsistent that phthalate exposure should
inhibit some enzymes while stimulatingothers. Con-
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sequently, phannacoldnetic studies would yield infor-
mation of greater potential value if distribution
data were obtained for specific cell fractions (endo-
plasmicreticulum, mitochondria, cytosol, etc.)rather
than for total tissue. The growing knowledge of
factors regulating particulate enzymes makes it
clear that relatively low levels of a chemical agent
in tissue may be misleading in terms of toxicity
potential, since levelsconsideredtobeinconsequen-
tial on a tissue or organ basis may be disastrously
high on an organellar basis.
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